BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6535647)

  • 1. Developmentally regulated surface structures of teratocarcinoma stem cells studied by mutant cell lines.
    Dráber P; Vojtísková M
    Cell Differ; 1984 Dec; 15(2-4):249-53. PubMed ID: 6535647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of adhesion of F9 embryonal carcinoma cells to substratum by a novel monoclonal antibody, TEC-05, reactive with a developmentally regulated carbohydrate epitope.
    Dráber P; Pokorná Z; Nosek J; Hinzová E
    Differentiation; 1988 May; 37(3):205-14. PubMed ID: 2458292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation antigens of mouse teratocarcinoma stem cells defined by monoclonal antibodies.
    Dráber P; Pokorná Z
    Cell Differ; 1984 Dec; 15(2-4):109-13. PubMed ID: 6535637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant embryonal carcinoma cells lacking SSEA-1 and Forsmann antigens remain developmentally pluripotent.
    Buckalew JJ; Sterman B; Rosenstraus M
    Dev Biol; 1985 Jan; 107(1):134-41. PubMed ID: 2856907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells.
    Andrews PW; Banting G; Damjanov I; Arnaud D; Avner P
    Hybridoma; 1984; 3(4):347-61. PubMed ID: 6396197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmentally regulated cell surface structures on mouse and human embryonal carcinoma cell lines.
    Avner P; Arnaud D; Blaineau C; Le Pendu J
    Cell Differ; 1985 Jul; 17(1):13-20. PubMed ID: 4028163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pluripotent human stem-cell clone isolated from the TERA-2 teratocarcinoma line lacks antigens SSEA-3 and SSEA-4 in vitro, but expresses these antigens when grown as a xenograft tumor.
    Andrews PW; Damjanov I; Simon D; Dignazio M
    Differentiation; 1985; 29(2):127-35. PubMed ID: 2412924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epitope of mouse embryonic antigen(s) recognized by monoclonal antibody TEC-02 is a carbohydrate carried by high-molecular-weight glycoconjugates.
    Dráber P
    Cell Differ; 1987 Jul; 21(2):119-30. PubMed ID: 2443254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and partial characterization of lectin-resistant F9 cells.
    Dráber P; Stanley P
    Somat Cell Mol Genet; 1984 Sep; 10(5):445-54. PubMed ID: 6591444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glycosidic antigen recognised by a novel monoclonal antibody, 75.12, is developmentally regulated on mouse embryonal carcinoma cells.
    Blaineau C; Le Pendu J; Arnaud D; Connan F; Avner P
    EMBO J; 1983; 2(12):2217-22. PubMed ID: 6667675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody which detects a 125 kd glycoprotein on embryonal carcinoma cells and is mitogenic for murine spleen cells.
    Stern P; Gilbert P; Sternberg S; Thompson S; Chada K
    J Reprod Immunol; 1984 Aug; 6(5):313-28. PubMed ID: 6207296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutants of embryonal carcinoma cells defective in the expression of embryoglycan.
    Dráber P; Malý P
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5798-802. PubMed ID: 2441394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of F9 antigens to spermatogenic cell antigens.
    Vojtísková M; Dráber P; Pokorná Z
    Cell Differ; 1984 Dec; 15(2-4):185-8. PubMed ID: 6152580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The surface glycolipid antigen specific for the internal cell mass of the mouse blastocyst and of the stem cells of murine teratocarcinoma F9].
    Anfimova ML; Bannikov GA; Troianovskiĭ SM
    Ontogenez; 1989; 20(2):158-63. PubMed ID: 2472584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syngeneic antiserum to Nulli SCC1 embryonal carcinoma cells recognizing surface antigens of embryonic cells.
    Hahnel AC; Eddy EM
    J Reprod Immunol; 1983 Nov; 5(6):371-82. PubMed ID: 6644686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mouse embryonic epitope TEC-2 on human carcinoma-derived cell lines and characterization of its glycoprotein carriers.
    Dráber P; Bubeník J; Pokorná Z; Jandlová T; Toulcová A
    Biochim Biophys Acta; 1988 Mar; 968(3):291-9. PubMed ID: 2449911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of an embryonal carcinoma cell line lacking SSEA-1 antigen.
    Rosenstraus MJ
    Dev Biol; 1983 Oct; 99(2):318-23. PubMed ID: 6137429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of plant lectins for mouse embryonal carcinoma cells.
    Dráber P; Stanley P
    Somat Cell Mol Genet; 1984 Sep; 10(5):435-43. PubMed ID: 6591443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual stage-specific embryonic antigen (TEC-4) defined by a monoclonal antibody to embryonal carcinoma cells defective in the expression of embryoglycan.
    Dráber P; Nosek J; Pokorná Z
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9337-41. PubMed ID: 2574458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD30 and its ligand: possible role in regulation of teratoma stem cells.
    Pera MF; Bennett W; Cerretti DP
    APMIS; 1998 Jan; 106(1):169-72; discussion 173. PubMed ID: 9524575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.